Angelo Gordon & Co’s ProKidney PROK Stock Holding History

Angelo Gordon & Co’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100,000	Closed	-$1M	–	264
2022 Q2	$1M	Hold	100,000	–	–	0.11%	90
2022 Q1	$990K	Hold	100,000	–	–	0.11%	97
2021 Q4	$990K	Hold	100,000	–	–	0.09%	118
2021 Q3	$980K	Hold	100,000	–	–	0.05%	125
2021 Q2	$1.01M	Buy	+100,000	New	+$1.01M	0.05%	107

Other funds holding PROK

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Angelo Gordon & Co's PROK Position: Q3 2022 in Review

Angelo Gordon & Co sold out of ProKidney (PROK) in Q3 2022, closing a stake of 100,000 shares — an estimated $1M sold.

Angelo Gordon & Co first reported a position in PROK in Q2 2021 and held it in 5 quarters. The position peaked at $1.01M in Q2 2021. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

Angelo Gordon & Co reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
Angelo Gordon & Co sold 100,000 ProKidney shares in Q3 2022, an estimated $1M.
Angelo Gordon & Co first reported a position in ProKidney in Q2 2021 and held it in 5 quarters.
Angelo Gordon & Co's ProKidney position peaked at $1.01M in Q2 2021.
18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Angelo Gordon & Co's 13F filing for Q3 2022, filed 14 Nov 2022.